These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 9750972

  • 21. The effect of 5-hydroxytryptophan on cholecystokinin-4-induced panic attacks in healthy volunteers.
    Maron E, Tõru I, Vasar V, Shlik J.
    J Psychopharmacol; 2004 Jun; 18(2):194-9. PubMed ID: 15260907
    [Abstract] [Full Text] [Related]

  • 22. Effects of tiagabine on cholecystokinin-tetrapeptide (CCK-4)-induced anxiety in healthy volunteers.
    Zwanzger P, Eser D, Padberg F, Baghai TC, Schule C, Rötzer F, Ella R, Möller HJ, Rupprecht R.
    Depress Anxiety; 2003 Jun; 18(3):140-3. PubMed ID: 14625878
    [Abstract] [Full Text] [Related]

  • 23. Dose ranging study of the effects of cholecystokinin in healthy volunteers.
    Bradwejn J, Koszycki D, Bourin M.
    J Psychiatry Neurosci; 1991 Jul; 16(2):91-5. PubMed ID: 1911739
    [Abstract] [Full Text] [Related]

  • 24. Central cholecystokinin activity in irritable bowel syndrome, panic disorder, and healthy controls.
    Koszycki D, Torres S, Swain JE, Bradwejn J.
    Psychosom Med; 2005 Jul; 67(4):590-5. PubMed ID: 16046372
    [Abstract] [Full Text] [Related]

  • 25. Effect of acute tryptophan depletion on behavioral, cardiovascular, and hormonal sensitivity to cholecystokinin-tetrapeptide challenge in healthy volunteers.
    Koszycki D, Zacharko RM, Le Melledo JM, Young SN, Bradwejn J.
    Biol Psychiatry; 1996 Oct 01; 40(7):648-55. PubMed ID: 8886299
    [Abstract] [Full Text] [Related]

  • 26. The acute antipanic and anxiolytic activity of aerobic exercise in patients with panic disorder and healthy control subjects.
    Ströhle A, Graetz B, Scheel M, Wittmann A, Feller C, Heinz A, Dimeo F.
    J Psychiatr Res; 2009 Aug 01; 43(12):1013-7. PubMed ID: 19289240
    [Abstract] [Full Text] [Related]

  • 27. Copeptin - A potential endocrine surrogate marker of CCK-4-induced panic symptoms?
    Demiralay C, Agorastos A, Yassouridis A, Jahn H, Wiedemann K, Kellner M.
    Psychoneuroendocrinology; 2017 Feb 01; 76():14-18. PubMed ID: 27871026
    [Abstract] [Full Text] [Related]

  • 28. Cholecystokinin and panic disorder: past and future clinical research strategies.
    Bradwejn J, Koszycki D.
    Scand J Clin Lab Invest Suppl; 2001 Feb 01; 234():19-27. PubMed ID: 11713976
    [Abstract] [Full Text] [Related]

  • 29. Effects of CCK-4 infusion on the acoustic eye-blink startle and psychophysiological measures in healthy volunteers.
    Shlik J, Zhou Y, Koszycki D, Vaccarino FJ, Bradwejn J.
    J Psychopharmacol; 1999 Dec 01; 13(4):385-90. PubMed ID: 10667615
    [Abstract] [Full Text] [Related]

  • 30. Acute and chronic role of 5-HT3 neuronal system on behavioral and neuroendocrine changes induced by intravenous cholecystokinin tetrapeptide administration in humans.
    Dépôt M, Caillé G, Mukherjee J, Katzman MA, Cadieux A, Bradwejn J.
    Neuropsychopharmacology; 1999 Feb 01; 20(2):177-87. PubMed ID: 9885797
    [Abstract] [Full Text] [Related]

  • 31. Effect of oral ondansetron on total cholecystokinin plasma levels following CCK-4 panic challenge procedure in healthy men.
    Dépôt M, Merani S, Bradwejn J, Mukherjee J, Caillé J, Gutkowska J, Caillé G.
    J Psychiatry Neurosci; 1998 Nov 01; 23(5):298-304. PubMed ID: 9846035
    [Abstract] [Full Text] [Related]

  • 32. Anxiolyticlike effects of atrial natriuretic peptide on cholecystokinin tetrapeptide-induced panic attacks: preliminary findings.
    Wiedemann K, Jahn H, Yassouridis A, Kellner M.
    Arch Gen Psychiatry; 2001 Apr 01; 58(4):371-7. PubMed ID: 11296098
    [Abstract] [Full Text] [Related]

  • 33. A dose-ranging study of the behavioral and cardiovascular effects of CCK-tetrapeptide in panic disorder.
    Bradwejn J, Koszycki D, Annable L, Couëtoux du Tertre A, Reines S, Karkanias C.
    Biol Psychiatry; 1992 Nov 15; 32(10):903-12. PubMed ID: 1467375
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Acute shift in glutamate concentrations following experimentally induced panic with cholecystokinin tetrapeptide--a 3T-MRS study in healthy subjects.
    Zwanzger P, Zavorotnyy M, Gencheva E, Diemer J, Kugel H, Heindel W, Ruland T, Ohrmann P, Arolt V, Domschke K, Pfleiderer B.
    Neuropsychopharmacology; 2013 Aug 15; 38(9):1648-54. PubMed ID: 23463151
    [Abstract] [Full Text] [Related]

  • 36. Acute effects of cholecystokinin tetrapeptide on brain stem auditory evoked potentials in healthy volunteers.
    Gunnarsson T, Mahoney C, Shlik J, Bradwejn J, Knott V.
    Pharmacopsychiatry; 2003 Sep 15; 36(5):181-6. PubMed ID: 14571352
    [Abstract] [Full Text] [Related]

  • 37. Neuropeptide S receptor gene variation modulates anterior cingulate cortex Glx levels during CCK-4 induced panic.
    Ruland T, Domschke K, Schütte V, Zavorotnyy M, Kugel H, Notzon S, Vennewald N, Ohrmann P, Arolt V, Pfleiderer B, Zwanzger P.
    Eur Neuropsychopharmacol; 2015 Oct 15; 25(10):1677-82. PubMed ID: 26235955
    [Abstract] [Full Text] [Related]

  • 38. Pentagastrin infusions in patients with panic disorder. I. Symptoms and cardiovascular responses.
    Abelson JL, Nesse RM.
    Biol Psychiatry; 1994 Jul 15; 36(2):73-83. PubMed ID: 7948449
    [Abstract] [Full Text] [Related]

  • 39. Influence of clonidine on psychopathological, endocrine and respiratory effects of cholecystokinin tetrapeptide in patients with panic disorder.
    Kellner M, Yassouridis A, Jahn H, Wiedemann K.
    Psychopharmacology (Berl); 1997 Sep 15; 133(1):55-61. PubMed ID: 9335081
    [Abstract] [Full Text] [Related]

  • 40. Effects of mental stress on cardiovascular and endocrine response in Air Force Academy cadets.
    Falaschi P, Proietti A, De Angelis C, Martocchia A, Giarrizzo C, Biselli R, D'Urso R, D'Amelio R.
    Neuro Endocrinol Lett; 2003 Sep 15; 24(3-4):197-202. PubMed ID: 14523357
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.